From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Weekly Wrap 18 September

Jessica Amir
September 18, 2020

Morning Bell 18 September

Bell Direct
September 18, 2020

Morning Bell 17th September

Jessica Amir
September 17, 2020

Morning Bell 16th September

Jessica Amir
September 16, 2020

Morning Bell 15 September

Jessica Amir
September 15, 2020

Morning Bell 14 September

Jessica Amir
September 14, 2020

Weekly Wrap 11 September

Jessica Amir
September 11, 2020

Morning Bell 11 September

Jessica Amir
September 11, 2020

Morning Bell 10 September

Jessica Amir
September 10, 2020

Morning Bell 9 September

Jessica Amir
September 9, 2020